Home » Stocks » EVGN

Evogene Ltd. (EVGN)

Stock Price: $3.78 USD 0.02 (0.53%)
Updated May 7, 2021 4:00 PM EDT - Market closed
After-hours: $3.77 -0.01 (-0.27%) May 7, 7:16 PM
Market Cap 164.62M
Revenue (ttm) 1.04M
Net Income (ttm) -23.37M
Shares Out 40.41M
EPS (ttm) -0.83
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $3.78
Previous Close $3.76
Change ($) 0.02
Change (%) 0.53%
Day's Open 3.79
Day's Range 3.69 - 3.98
Day's Volume 345,071
52-Week Range 0.94 - 10.24

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

REHOVOT, Israel, April 19, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd.

2 weeks ago - PRNewsWire

Analysts say these penny stocks are a buy right now & have bullish price targets to boot. The post Penny Stocks To Buy According To Analysts With Price Targets Up to 341% appeared first on Penny Stocks ...

Other stocks mentioned: PAVM, SVRA, SYBX
2 weeks ago - PennyStocks

REHOVOT, Israel, April 13, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd.

3 weeks ago - PRNewsWire

REHOVOT, Israel, April 7, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company today announced that it will hold virtual investor and analyst days, in ...

1 month ago - PRNewsWire

REHOVOT, Israel , April 2, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing product discovery and development in multiple...

1 month ago - PRNewsWire

REHOVOT, Israel and TEL-AVIV, Israel, March 25, 2021 /PRNewswire/ -- Canonic Ltd., a subsidiary of Evogene Ltd.

1 month ago - PRNewsWire

ST. LOUIS, Mo. and REHOVOT, Israel, March 17, 2021 /PRNewswire/ -- Plastomics, Inc., an agricultural biotech company, developing a step change in trait delivery technology, and Evogene Ltd.

1 month ago - PRNewsWire

REHOVOT, Israel, March 3, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product discovery and developm...

2 months ago - PRNewsWire

TEL AVIV and REHOVOT, Israel, Feb. 24, 2021 /PRNewswire/ -- Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. (TASE: TKUN), a leading medical cannabis company, and Canonic Ltd., a subsidiary of Evog...

2 months ago - PRNewsWire

REHOVOT, Israel, Jan. 20, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (T...

3 months ago - PRNewsWire

REHOVOT, Israel, Dec. 23, 2020 /PRNewswire/ -- Canonic Ltd, a company focused on the development of medical cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) an...

4 months ago - PRNewsWire

While most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Other stocks mentioned: AR, MGY, NBEV, AGS
4 months ago - 24/7 Wall Street

Evogene Ltd. (EVGN) CEO Ofer Haviv on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

REHOVOT, Israel, Nov. 18, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development across sever...

5 months ago - PRNewsWire

REHOVOT, Israel, Nov. 2, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several ma...

6 months ago - PRNewsWire

REHOVOT, Israel, Oct. 30, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company focused on revolutionizing product discovery and development in multiple...

6 months ago - PRNewsWire

Despite its recent share price increase, Evogene continues to be undervalued given the sum of parts valuation of its 4 main subsidiaries and $45 million cash position.

7 months ago - Seeking Alpha

REHOVOT, Israel, Sept. 9, 2020 /PRNewswire/ -- Evogene Ltd.

7 months ago - PRNewsWire

Evogene: Hidden Gems Of Computational Predictive Biology (Part 3 Of 4) - Ag Plenus (Novel Herbicides And Pesticides)

8 months ago - Seeking Alpha

REHOVOT, Israel, Sept. 1, 2020 /PRNewswire/ -- Evogene Ltd.

8 months ago - PRNewsWire

Evogene: Hidden Gems Of Computational Predictive Biology, Part 2 Of 4 - Lavie Bio

8 months ago - Seeking Alpha

REHOVOT, Israel, Aug. 19, 2020 /PRNewswire/ -- Evogene Ltd.

8 months ago - PRNewsWire

Evogene Ltd. has developed a unique Computational Predictive Biology platform, leveraging big data and artificial intelligence to life-science products such as microbes, small molecules and genes.

8 months ago - Seeking Alpha

Evogene Ltd. (EVGN) CEO Ofer Haviv on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

REHOVOT, Israel, July 29, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading artificial intelligence company targeting to revolutionize life-science product development across s...

9 months ago - PRNewsWire

REHOVOT, Israel, July 15, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across sev...

9 months ago - PRNewsWire

REHOVOT, Israel, June 3, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across seve...

11 months ago - PRNewsWire

Evogene Ltd (EVGN) CEO Ofer Haviv on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

REHOVOT, Israel, May 26, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across seve...

11 months ago - PRNewsWire

REHOVOT, Israel, May 20, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across seve...

11 months ago - PRNewsWire

Evogene's (EVGN) CEO Ofer Haviv on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Evogene's (EVGN) CEO Ofer Haviv on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Evogene Ltd (EVGN) CEO Ofer Haviv on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Evogene Ltd. (NASDAQ: EVGN) is amending its collaboration with Bayer AG (OTC: BAYRY)'s crop science division to identify genome editing targets for evaluation against a broad range of corn diseases.

Other stocks mentioned: BAYRY
1 year ago - Benzinga

In the small- and micro-cap section of the market, there's a whole selection of companies that are trading at what look to be deeply discounted valuations right now.

Other stocks mentioned: HCHC, NVFY
1 year ago - GuruFocus

Evogene Ltd. (EVGN) CEO Ofer Haviv on Q1 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

It's not unusual these days to see agri-tech and biotech stocks jumping on the cannabis bandwagon to capitalize on the opportunity presented by the geographically expanding legalization of pot.

2 years ago - Benzinga

Agricultural engineering company Evogene Ltd. has announced the establishment of a new subsidiary, called Canonic, to develop next-generation medical cannabis product

2 years ago - 24/7 Wall Street

About EVGN

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and... [Read more...]

Industry
Biotechnology
Founded
1999
Stock Exchange
NASDAQ
Ticker Symbol
EVGN
Full Company Profile

Financial Performance

In 2020, Evogene's revenue was $1.04 million, an increase of 38.11% compared to the previous year's $753,000. Losses were -$23.37 million, 29.1% more than in 2019.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for Evogene stock is "Strong Buy" and the 12-month stock price forecast is 15.00.

Price Target
$15.00
Analyst Consensus: Strong Buy